Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer

Comment: Research developments stir hopes for melanoma

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer

PARP inhibitor combo shows early promise for patients with and without BRCA mutations

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma

Long-term, regular aspirin use modestly decreased cancer risk

Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

DNA stool test recommended as screening tool for colon cancer

What are the objectives for CART-meso immunotherapy?

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

How will genomics be applied to patient therapy in future?